4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-17-063683
Director sold 6,667 shares at $55.89 ($372,619)
- Director acquired 6,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Wigzell Hans Lennart Rudolf · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-30 | Exercise or conversion : show line 1 in the form | +6,667 | $7.38 | $49,202 | 13,333 | D |
| 2017-11-30 | Sale : show line 2 in the form | −6,667 | $55.89 | $372,619 | 6,666 | D |
| Open-market sales · 6,667 sh · avg $55.89 · $372,619 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2017-11-30 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Options (right to buy) | −6,667 | $7.38 | $49,202 | $7.38 | 2018-07-23 | 6,667 | 0 | D |
Loading xslF345X03/doc4.xml…